ARCH VENTURE PARTNERS
ARCH invests primarily in companies co-founded by scientists and entrepreneurs, concentrating on bringing to market innovations in life sciences. They enjoy special recognition as a leader in the successful commercialization of technologies developed at academic research institutions and national laboratories. ARCH has raised ten venture funds totaling over $3 billion and has invested in the earliest venture capital rounds for more than 150 companies. ARCH investors include major corporations, pension funds, endowment funds, financial institutions, and private investors.
ARCH VENTURE PARTNERS
Social Links:
Industry:
Finance Financial Services Venture Capital
Founded:
1986-01-01
Status:
Active
Contact:
773-380-6600
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Sitelinks Search Box Yoast WordPress SEO Plugin
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Current Advisors List
Maurice Treacy Venture Partner @ ARCH Venture Partners Board_member 2014-01-01
Steven Gillis Member of Board of Directors @ ARCH Venture Partners Board_member 2005-01-01
Current Employees Featured
Keith Crandell
Keith Crandell Founder and Managing Director @ ARCH Venture Partners Founder and Managing Director
Robert Nelsen
Robert Nelsen Co-Founder & Managing Director @ ARCH Venture Partners Co-Founder & Managing Director 1986-01-01
Clinton Bybee
Clinton Bybee Co-Founder and Managing Director @ ARCH Venture Partners Co-Founder and Managing Director 1988-01-01
Mark McDonnell
Mark McDonnell Managing Director, Chief Financial and Chief Administrative Officer @ ARCH Venture Partners Managing Director, Chief Financial and Chief Administrative Officer
Kristina Burow
Kristina Burow Managing Director @ ARCH Venture Partners Managing Director 2002-01-01
Steven Lazarus
Steven Lazarus Co-founder and Managing Director, Emeritus Chicago @ ARCH Venture Partners Co-founder and Managing Director, Emeritus Chicago
Hong Hou
Hong Hou Venture Partner @ ARCH Venture Partners Venture Partner
Cindy Bayley
Cindy Bayley Affiliate @ ARCH Venture Partners Affiliate
Keith Lenden
Keith Lenden Venture Partner @ ARCH Venture Partners Venture Partner 2017-01-01
Jonathan Lim
Jonathan Lim Venture Partner @ ARCH Venture Partners Venture Partner 2018-12-01
Founder
Clinton Bybee
Keith Crandell
Robert Nelsen
Steven Lazarus
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-09-08 | Autobahn Therapeutics | ARCH Venture Partners investment in Venture Round - Autobahn Therapeutics | 32.7 M USD |
2022-09-07 | Orbital Therapeutics | ARCH Venture Partners investment in Seed Round - Orbital Therapeutics | N/A |
2022-09-06 | Elephas | ARCH Venture Partners investment in Series B - Elephas | 41.5 M USD |
2022-08-29 | Vilya | ARCH Venture Partners investment in Series A - Vilya | 50 M USD |
2022-08-24 | Happy Health | ARCH Venture Partners investment in Series A - Happy Health | 60 M USD |
2022-08-03 | Homeward | ARCH Venture Partners investment in Series B - Homeward | 50 M USD |
2022-08-02 | Sironax | ARCH Venture Partners investment in Series B - Sironax | 200 M USD |
2022-07-12 | Areteia Therapeutics | ARCH Venture Partners investment in Series A - Areteia Therapeutics | 350 M USD |
2022-06-03 | Vizgen | ARCH Venture Partners investment in Series C - Vizgen | 85.2 M USD |
2022-05-17 | Remix Therapeutics | ARCH Venture Partners investment in Series B - Remix Therapeutics | 70 M USD |